You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hematologic response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Profiling for Cancer Immunotherapy Response

Recruiting
  • Cancer
  • +3 more
  • Methylation Cytometry
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Nov 6, 2023

Tyrosine Kinase Inhibitors on Liver Enzymes and Electrolytes

Active, not recruiting
  • Patients Diagnosed as Chronic Meyloid Leukemia
  • Tyrosine kinase Inhibitors (Imatinib & Nilotinib)
  • Assiut, Egypt
    Assiut University Hospital
Feb 19, 2022

Solid Tumor, Adult, Solid Tumor, Childhood, Hematologic Cancer Trial in Villejuif (Tumor biopsy, Blood sample, Bone marrow

Recruiting
  • Solid Tumor, Adult
  • +2 more
  • Tumor biopsy
  • +2 more
  • Villejuif, Val De Marne, France
    Gustave Roussy Cancer Campus Grand Paris
Jul 28, 2022

Response to Influenza Vaccination in Pediatric Oncology Patients

Recruiting
  • Hematologic Malignancy
  • +2 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Oct 17, 2022

    Sars-Covid-19 Vaccines in Haematological Patients: Prospective

    Completed
    • Hematologic Diseases
    • IgG antibodies to Sars-Cov-2
    • QuantiFERON SARS-CoV-2 test
    • Monza, Lombardia, Italy
      San Gerardo Hospital
    Jan 23, 2023

    CAR-T Treatment for Hematological Malignancies

    Recruiting
    • Hematological Malignancies
    • Chimeric Antigen Receptor T-cell Therapy
      • Suzhou, Jiangsu, China
        The First Affiliated Hospital of Soochow University
      Sep 11, 2023

      SARS-CoV-2 Vaccine in Stem Cell Transplant and Cellular Therapy

      Recruiting
      • Hematologic Disorders and Bone Marrow Failure, Hematopoietic Stem Cell Transplantation (HSCT) or Cellular Therapy (CART)
      • COVID-19 serology IgG
      • Detroit, Michigan
        Henry Ford Health System
      Jul 19, 2022

      Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Tumor Trial in Houston (Recombinant

      Active, not recruiting
      • Allogeneic Hematopoietic Stem Cell Transplant Recipient
      • Hematopoietic and Lymphoid Cell Neoplasm
      • Recombinant Human Papillomavirus Nonavalent Vaccine
      • Houston, Texas
        M D Anderson Cancer Center
      Jun 29, 2022

      Toxicity inHaematological Malignancy Treated With Immunotherapy.

      Recruiting
      • Blood Cancer
      • Data collection
      • Paris, Ile De France, France
        Assistance Publique - Hôpitaux de Paris (AP-HP) - Cochin Hospita
      Jul 5, 2022

      Multiple Myeloma, AL Amyloidosis, Chronic Lymphocytic Leukemia Trial in Detroit (A single "booster" dose of the Moderna mRNA

      Recruiting
      • Multiple Myeloma
      • +2 more
      • A single "booster" dose of the Moderna mRNA COVID-19 vaccine
      • Detroit, Michigan
        Barbara Ann Karmanos Cancer Institute
      Apr 12, 2022

      COVID-19 Vaccines in Cancer, Transplant or Cellular Therapy

      Recruiting
      • Cancer
      • +7 more
        • Memphis, Tennessee
        • +2 more
        Mar 2, 2022

        Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)

        Completed
        Has Results
        • Aplastic Anemia
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Jul 2, 2021

        Rational Treatment Trials of Blood Cancer

        Completed
        • Hematologic Diseases
        • Treatment
        • ex-vivo drug response assay
        • Heidelberg, Germany
          University Hospital Heidelberg
        Nov 30, 2021

        Immunocompromised Haematology Patients

        Active, not recruiting
        • Covid19
        • +2 more
        • Blood test
        • Stoke-on-Trent, United Kingdom
          University Hospitals of North Midlands NHS Trust
        Feb 17, 2022

        COVID-19 Vaccine Efficacy in Patients With Malignant Pathologies

        Recruiting
        • Solid Tumor
        • +4 more
        • Data collection
        • Paris, France
        • +1 more
        Nov 26, 2021

        Covid19, Hematologic Malignancy, Vaccine Response Impaired Trial in Quimper (Patients with hemopathy)

        Recruiting
        • Covid19
        • +2 more
        • Patients with hemopathy
        • Quimper, France
          Centre Hospitalier de Quimper Cornouaille
        Apr 20, 2021

        Immunogenicity of Covid-19 Vaccination for Hematological

        Active, not recruiting
        • Immunogenicity
        • +3 more
          • Varese, Lombardia, Italy
            UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
          Sep 10, 2021

          High Risk MDS or AML Patients Trial in Philadelphia (Exjade® (deferasirox, ICL670))

          Completed
          • High Risk MDS or AML Patients
          • Exjade® (deferasirox, ICL670)
          • Philadelphia, Pennsylvania
            Abramson Cancer Center of the University of Pennsylvania
          Apr 7, 2020

          Against Delta-CD20 Peptide in Hematological Malignancies B

          Terminated
          • Hematological Malignancies B
          • additional biological samples
          • Besançon, France
            Centre Hospitalier Régional Universitaire de Besançon
          Jan 29, 2021

          Innate CD8+ T Cells and Evolution of Tyrosine Kinase Inhibitor

          Recruiting
          • Leukemia
          • +3 more
          • Phenotyping of total and innate CD8+T cells by flow cytometry
          • Nîmes, Gard, France
            CHU de Nîmes
          Jul 19, 2021

          CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

          Recruiting
          • CML
          • +3 more
          • Asciminib add-on
          • +3 more
          • Augusta, Georgia
          • +46 more
          Jan 23, 2023

          Light Chain (AL) Amyloidosis, CCND1 Translocation, Venetoclax Trial (Venetoclax, Dexamethasone Oral)

          Not yet recruiting
          • Light Chain (AL) Amyloidosis
          • +2 more
          • (no location specified)
          Aug 16, 2023

          National Project on Vaccines, COVID-19 and Frail Patients

          Recruiting
          • COVID-19
          • +4 more
          • COVID-19 vaccines
          • Bologna, Bologhna, Italy
          • +11 more
          Apr 21, 2021

          Chimeric Antigen Receptor-T Cells Therapy in Hematologic

          Not yet recruiting
          • Hematologic Diseases
            • (no location specified)
            Dec 20, 2019

            Discontinuing Tyrosin Kinase Inhibitors in Chronic Myeloid

            Completed
            • Hematologic Diseases
            • Chronic Myeloid Leukemia
            • Budget impact
            • Bordeaux, France
              CHU Bordeaux
            Apr 27, 2020